Commonly prescribed GLP-1 agonists in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus [oral formulation for diabetes]) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta, Bydureon) - availability may vary Whilst initially licensed for glycaemic control, certain GLP-1 medications have received regulatory approval for weight management in adults with obesity or overweight with weight-related comorbidities
This treatment is not for anyone who has chronic kidney disease or whose creatinine levels exceed 2.5mg/dl
Regensteiner JG, Golden S, Huebschmann AG et al (2015) Sex differences in the cardiovascular consequences of diabetes mellitus: a Scientific Statement From the American Heart Association
If youre ready to take a holistic approach to your health that goes beyond just medication, were here to guide you
Likewise, liraglutide 1.8 and 3.0 mg were associated with similar reductions in total and incremental insulin and C-peptide AUCs in the first hour, including reductions in insulin and C-peptide iAUC 060 min of 20% compared with placebo (Table 2)
Vyleesi is a trade name of Palatin Technologies, Inc